Price T Rowe Associates Inc Ab Cellera Biologics Inc. Transaction History

Price T Rowe Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$7.31 - $11.18 $28,896 - $44,194	3,953 Added 10.99%	39,916 $301,000
Q4 2022 Feb 14, 2023	BUY	$9.48 - $14.52 $21,320 - $32,655	2,249 Added 6.67%	35,963 $364,000
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $128,385 - $190,904	13,955 Added 70.63%	33,714 $334,000
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $113,021 - $210,433	19,759 New	19,759 $210,000

153

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $787M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.